Peripartum cardiomyopathy (
PPCM) is a condition of unknown etiology that presents as heart failure due to left ventricular systolic dysfunction in the last of month of pregnancy and up to six months after giving birth and manifests in women without any previous known heart disease.1 Incidence and prevalence of
PPCM varies worldwide.
"Our study shows that the risk of
PPCM is five times higher in women who have fertility treatment so they should be aware that this discomfort may not be benign.
The pollen count in Islamabad was at its highest in nine years on Tuesday at 82,270
PPCM and the pollen count in H-8 on that day was 43,330
PPCMA high rate was also observed in the study investigating patients with
PPCM (5 appropriate shocks in 49 patients) [16].
Keith Howells, chairman of Mott MacDonald, said: "We're delighted that John has joined us to take on the challenge of growing our global
PPCM businesses.
PPCM is characterised by the enlarging of the heart around the time of childbirth.
Though this disease process is not as well studied, it has been suggested to be phenotypically identical to
PPCM and without clinical differences in presentation, management, or prognosis [1].
Wide variations exist regarding the true incidence of
PPCM, with several reports placing it between 1 in 300 pregnancies in places of high incidence, such as Haiti, and 1 in 4025 in areas in which the incidence is lower, such as the United States and other western societies (2-6).
PPCM is a rare form of dilated cardiomyopathy associated with pregnancy.
Early diagnosis, treatment, and clinician being familiar with this disease are the basic factors that improve the prognosis.3 In our case, we aimed to present the diagnosis and treatment of
PPCM.
These findings will enable physicians to perform a blood test and determine if a woman has
PPCM and start effective treatment, resulting in markedly decreased mortality.